Mitsubishi UFJ Asset Management UK Ltd. purchased a new position in shares of Ingevity Co. (NYSE:NGVT – Free Report) in the 4th quarter, Holdings Channel reports. The firm purchased 13,000 shares of the company’s stock, valued at approximately $530,000.
A number of other large investors also recently bought and sold shares of NGVT. Envestnet Asset Management Inc. raised its holdings in shares of Ingevity by 4.0% in the 2nd quarter. Envestnet Asset Management Inc. now owns 58,145 shares of the company’s stock worth $2,542,000 after purchasing an additional 2,262 shares during the period. Dimensional Fund Advisors LP raised its holdings in Ingevity by 11.6% in the second quarter. Dimensional Fund Advisors LP now owns 845,912 shares of the company’s stock valued at $36,977,000 after buying an additional 88,026 shares during the period. Hsbc Holdings PLC lifted its position in Ingevity by 29.4% during the second quarter. Hsbc Holdings PLC now owns 34,890 shares of the company’s stock valued at $1,529,000 after buying an additional 7,935 shares in the last quarter. Inspire Investing LLC grew its stake in Ingevity by 8.0% during the second quarter. Inspire Investing LLC now owns 8,013 shares of the company’s stock worth $350,000 after buying an additional 596 shares during the period. Finally, Sei Investments Co. increased its position in shares of Ingevity by 23.9% in the second quarter. Sei Investments Co. now owns 162,627 shares of the company’s stock worth $7,108,000 after acquiring an additional 31,406 shares in the last quarter. Hedge funds and other institutional investors own 91.59% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, BMO Capital Markets lifted their target price on shares of Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $52.17.
Ingevity Trading Up 1.1 %
NGVT opened at $47.73 on Wednesday. The firm’s 50 day moving average is $44.08 and its 200-day moving average is $40.77. Ingevity Co. has a 52-week low of $30.90 and a 52-week high of $56.29. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 6.52. The firm has a market capitalization of $1.73 billion, a P/E ratio of -3.07 and a beta of 1.65.
Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.50. The firm had revenue of $376.90 million for the quarter, compared to the consensus estimate of $376.95 million. Ingevity had a negative net margin of 38.11% and a positive return on equity of 24.46%. The firm’s quarterly revenue was down 15.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.21 EPS. Analysts expect that Ingevity Co. will post 2.75 EPS for the current fiscal year.
Ingevity Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Featured Stories
- Five stocks we like better than Ingevity
- Ride Out The Recession With These Dividend Kings
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How to Use Stock Screeners to Find Stocks
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Co. (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.